A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Patients with symptomatic advanced chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations are particularly at risk of poor outcomes and present a significant burden on healthcare systems. The relative merits of treating with different inhaled combination therapies e.g. i...

Full description

Bibliographic Details
Main Authors:	Pascoe, S, Lipson, D, Locantore, N, Barnacle, H, Brealey, N, Mohindra, R, Dransfield, M, Pavord, I, Barnes, N
Format:	Journal article
Language:	English
Published:	European Respiratory Society 2016

Similar Items

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
by: Pascoe, S, et al.
Published: (2018)

Blood eosinophil levels as a biomarker in COPD
by: Brusselle, G, et al.
Published: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
by: Andrea Benedetti, et al.
Published: (2022-07-01)

EFFECTIVENESS OF TRIPLE DRUG FIXED DOSE COMBINATION INHALED THERAPY IN SEVERE COPD PATIENTS
by: Vrunda B Patel, et al.
Published: (2018-03-01)

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
by: Lee, LA, et al.
Published: (2020)

The Lancet COPD Commission: broader questions remain
by: Petousi, N, et al.
Published: (2023)

SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers
by: Natasha Smallwood, et al.
Published: (2022-08-01)

Symptomatic COPD: is it time for triple therapy?
by: Bafadhel, M
Published: (2018)

Triple therapy in COPD: understanding the data
by: Samy Suissa
Published: (2023-01-01)

DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients
by: Hans Gelderblom, et al.
Published: (2024-08-01)

COPD and hepatitis C.
by: Pavord, I, et al.
Published: (2003)

COPD: an autoimmune disease?
by: Birring, S, et al.
Published: (2011)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
by: López-Campos JL, et al.
Published: (2020-07-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
by: Garegrat, R, et al.
Published: (2024)

Inhaled corticosteroids in COPD.
by: Brightling, C, et al.
Published: (1999)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
by: Sonja Vliek, et al.
Published: (2023-09-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
by: Pavord, I, et al.
Published: (2017)

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution
by: Fulvio Braido, et al.
Published: (2022-01-01)

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial
by: Gabrio A, et al.
Published: (2022-07-01)

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
by: Day, N, et al.
Published: (2014)

Triple Therapy for COPD: Historical Perspective and Current Controversies
by: Jose L. López-Campos
Published: (2023-01-01)

Current appraisal of single inhaler triple therapy in COPD
by: Lipworth B, et al.
Published: (2018-09-01)

Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol
by: Stephanie Stock, et al.
Published: (2020-01-01)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
by: Reema Garegrat, et al.
Published: (2024-07-01)

Determinants of successful completion of pulmonary rehabilitation in COPD
by: Brown AT, et al.
Published: (2016-02-01)

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
by: Singh S, et al.
Published: (2018-01-01)

COPD exacerbation phenotypes: The next frontier
by: Moran, A, et al.
Published: (2019)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
by: Nicola C. Day, et al.
Published: (2020-06-01)

Prednisolone response in patients with COPD.
by: Pavord, I, et al.
Published: (2004)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial
by: Rowe SM, et al.
Published: (2020-10-01)

Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial
by: Pawan Kumar Singh, et al.
Published: (2023-07-01)

Assessment of inflammation in COPD: Observed cell profiles and the effects of treatment
by: Pavord, I
Published: (2002)

Symptomatic burden of COPD for patients receiving dual or triple therapy
by: Chen S, et al.
Published: (2018-04-01)

Effectiveness of manual therapy in COPD: A systematic review of randomised controlled trials
by: C. Simonelli, et al.
Published: (2019-07-01)

Participate CP 2: optimising participation in physically active leisure for children with cerebral palsy – protocol for a phase III randomised controlled trial
by: Robert S Ware, et al.
Published: (2023-10-01)